U.S. SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, DC 20549

                                  FORM 10-QSB

               Quarterly report under to Section 13 or 15(d) of
                      the Securities Exchange Act of 1934


                For the quarterly period ended FEBRUARY 2, 2002

                          Commission File No. 0-1455


                          OPT - SCIENCES CORPORATION
    (Exact name of small business issuer as specified in its charter)


             NEW JERSEY                           21-0681502
    (State or other jurisdiction of              (I.R.S. Employer
    incorporation or organization)               identification number)



   1912 BANNARD STREET, RIVERTON, NJ                   08077
   (Address of principal executive offices)           (Zip Code)



Registrant's telephone number, including area code:    856-829-2800

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past twelve months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

                       Yes      X          No__________


State the number of shares outstanding of each of the issuer's classes of
common equity, as of the latest practicable date:


            CLASS                    OUTSTANDING AT FEBRUARY 2, 2002
COMMON STOCK, PAR VALUE $0.25           775,585 SHARES

#


<PAGE>





                                     INDEX




PART I     FINANCIAL INFORMATION

Item 1.    Financial Statements

           Consolidated Balance Sheets - February 2,
           2002 and October 27, 2001                           3

           Consolidated Statements of Income -
           fourteen weeks ended February 2, 2002 and
           thirteen weeks ended January 27, 2001               5

           Consolidated Statements of Cash Flows -
           fourteen weeks ended February 2, 2002 and
           thirteen weeks ended January 27, 2001               6

           Notes to Consolidated Financial Statements          7

Item 2.    Management's Discussion and Analysis or Plan
           of Operation                                        8


PART II    OTHER INFORMATION

Item 1     Not Applicable

Item 2     Not Applicable

Item 3     Not Applicable

Item 4     Not Applicable

Item 5     Not Applicable

Item 6     Not Applicable


SIGNATURE

<PAGE>

                          ASSETS


                               February 2,          October 27,
                               2002                    2001
 CURRENT ASSETS

 Cash and cash equivalents  $ 4,421,844         $  4,424,969
 Trade accounts receivable      713,997            1,055,356
 Inventories                    404,303              429,056
 Prepaid expenses                34,587               38,982
 Marketable securities        1,166,723            1,082,483

 Total current assets         6,741,454            7,030,846


 PROPERTY AND EQUIPMENT

 Land                           114,006              114,006
 Building and improvements      418,312              346,571
 Machinery and equipment      1,212,241            1,212,241
 Small tools                     53,580               53,580
 Furniture and fixtures           8,048                8,048
 Office equipment                50,924               50,924
 Automobiles                     60,100               60,100

 Total property and
 equipment                    1,917,211            1,845,470

 Less: accumulated depreciation
                              1,050,367            1,033,207

 Net property and
 equipment                      866,844              812,263

 OTHER ASSETS

 Deposits                         2,837                2,837

 Total assets            $    7,611,135       $    7,845,946

<PAGE>

            LIABILITIES AND STOCKHOLDERS' EQUITY

                                February 2,           October 27,
                                 2002                     2001
 CURRENT LIABILITIES

 Accounts payable - trade  $       122,988       $       270,877
 Accrued income taxes              140,377               139,096
 Other current liabilities          71,954               255,466

 Total current liabilities         335,319               665,439


 STOCKHOLDERS' EQUITY

 Common capital stock - par value
 $.025 per share - authorized
 and issued 1,000,000 shares        250,000              250,000
 Additional paid in capital         272,695              272,695
 Retained earnings                6,975,677            6,898,523
 Accumulated other comprehensive income
                                    (35,338)             (53,493)
 Less treasury stock at cost -
 224,415 shares                    (187,218)            (187,218)

 Total stockholders' equity       7,275,816            7,180,507

 Total liabilities and
 stockholders' equity             7,611,135       $    7,845,946


<PAGE>


                         Fourteen Weeks            Thirteen Weeks
                         Ended                     Ended
                         February 2, 2002          January 27, 2001

 NET SALES                $     1,198,789           $    1,069,646

 COST OF SALES                    913,234                  738,134

 Gross profit on sales            285,555                  331,512

 OPERATING EXPENSES

 Sales & delivery                  33,591                   21,084
 General and administrative       145,208                  149,713

 Total operating expenses         178,799                  170,797

 Operating income                 106,756                  160,715

 OTHER INCOME                      24,898                   60,257

 Net income before taxes          131,654                  220,972

 FEDERAL AND STATE
 INCOME TAXES                      54,500                   95,000

 Net income                        77,154                  125,972

 RETAINED EARNINGS -
 beginning of period            6,898,523                6,249,750

 RETAINED EARNINGS -
 end of period          $       6,975,677    $           6,375,722

 EARNINGS PER SHARE OF
 COMMON STOCK                        0.10                     0.16

 Average shares of stock
 outstanding                      775,585                  775,585


<PAGE>

                               Fourteen Weeks        Thirteen Weeks
                               Ended February 2,     Ended January 27,
                                   2002                  2001
 CASH FLOWS FROM OPERATING ACTIVITIES
 Net income                          $   77,154     $    125,972

 Adjustments to reconcile net income to net
 cash provided by operating activities:
 Depreciation                            17,160           18,429
 Loss on sale of securities              12,054           18,217

 Decrease (increase) in:
 Accounts receivable                    341,359         (188,529)
 Inventories                             24,753         (109,420)
 Prepaid expenses                         4,395           98,201

 (Decrease) increase in:
 Accounts payable                       (16,108)         (38,623)
 Accrued income taxes                  (130,500)             -0-
 Other current liabilities             (183,512)         (99,645)

 Net cash provided (used)
 by operating activities                146,755         (175,398)

 CASH FLOWS FROM INVESTING ACTIVITIES
 Additions to property and equipment    (71,741)             -0-
 Purchases of securities               (161,537)        (475,819)
 Sale of securities                      83,398          104,081

 Net (used) by investing activities    (149,880)        (371,738)

 (Decrease) in cash                      (3,125)        (547,136)

 Cash and cash equivalents
 at beginning of period               4,424,969        4,196,034

 Cash and cash equivalents
 at end of period              $      4,421,844   $    3,648,898

 SUPPLEMENTAL DISCLOSURES:
 Interest  paid                             -0-               -0-

 Income taxes paid                  $   185,000         $     -0-


<PAGE>
                    OPT-Sciences Corporation and Subsidiary
                    NOTES TO CONDENSED FINANCIAL STATEMENTS
                                  (Unaudited)



<PAGE>
                    OPT-Sciences Corporation and Subsidiary
                    NOTES TO CONDENSED FINANCIAL STATEMENTS
                                  (Unaudited)







1. In  the  opinion  of  management,  the  accompanying  unaudited consolidated
   financial  statements contain all adjustments necessary  to  present  fairly
   OPT-Sciences  Corporation's  financial  position  as of February 2, 2002 and
   October 27, 2001, and the results of operations for the fourteen weeks ended
   February  2, 2002 and the thirteen weeks ended January  27,  2001  and  cash
   flows for the respective periods then ended.

2. The results  of  operations  for  the  periods presented are not necessarily
   indicative of the results to be expected for the full year.


<PAGE>






                    MANAGEMENT'S DISCUSSION AND ANALYSIS OF

                 FINANCIAL CONDITION AND RESULTS OF OPERATIONS




FINANCIAL CONDITION


Cash and cash equivalents - OPT Sciences Corporation's  cash balances decreased
during  the  first  three  months  of the year from $4,424,969  to  $4,421,844.
Profits  generated,  were  offset  by purchases  of  equipment  and  marketable
securities.   There are no material obligations  in  existence  that  would  be
anticipated to  cause  any substantial decrease in the cash balances from other
than the Company's future operations.


RESULTS OF OPERATIONS

Sales revenues have increased  by  about  12% from the level of the first three
months of the prior year.  Gross profits fell  off  as  the  labor force needed
throughout  the  prior period was excessive for this volume level.   Management
has reviewed staffing  levels  and is in the process of making changes.  Income
from investments decreased as funds  were shifted into securities from interest
bearing savings accounts and securities that were deemed undesirable were sold.




<PAGE>






                                  SIGNATURES



In accordance with the requirements of the Exchange Act, the registrant this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                                              OPT-SCIENCE CORPORATION
                                              Registrant




     Date                                     Anderson McCabe, President





     Date                                     Harvey Habeck,
                                              Chief Accountant